Title:
COMPOSITION FOR CONTROLLING IN VIVO DRUG DISSOLUTION
Document Type and Number:
WIPO Patent Application WO/2018/074496
Kind Code:
A1
Abstract:
The present invention addresses the problem of providing one or more of: a novel substance functioning to control in vivo drug dissolution; a novel agent for controlling in vivo drug dissolution; a solid medicinal preparation exhibiting controlled drug dissolution; and production processes therefor.
The present invention provides a composite characterized by comprising tannic acid and a drug (optionally further containing an inert carrier and/or a lower alcohol) and giving, in an examination with a Fourier transform infrared spectrophotometer, an infrared absorption spectrum in which at least one of the peaks assignable to the functional groups of the drug is not detected. Also provided are a solid medicinal preparation containing the composite and processes for producing the composite and the solid medicinal preparation.
Inventors:
SHIMATANI TAKAO (JP)
YAMADA ATSUSHI (JP)
YAMADA ATSUSHI (JP)
Application Number:
PCT/JP2017/037614
Publication Date:
April 26, 2018
Filing Date:
October 18, 2017
Export Citation:
Assignee:
TEIKA PHARMACEUTICAL CO LTD (JP)
International Classes:
A61K9/22; A61K47/10; A61K47/22
Domestic Patent References:
| WO2015160678A1 | 2015-10-22 |
Foreign References:
| JP2010513280A | 2010-04-30 | |||
| US20050202080A1 | 2005-09-15 | |||
| JP2015078166A | 2015-04-23 |
Attorney, Agent or Firm:
IWATANI, Ryo (JP)
Download PDF:
Previous Patent: POLYAMIDE RESIN COMPOSITION
Next Patent: ANTI-ATHEROSCLEROTIC AGENT AND SYMPTOM IDENTIFICATION METHOD FOR ARTERIOSCLEROSIS
Next Patent: ANTI-ATHEROSCLEROTIC AGENT AND SYMPTOM IDENTIFICATION METHOD FOR ARTERIOSCLEROSIS